FDA authorizes first diagnostic test for COVID-19 antibodies that obstruct the virus from entering cells
The FDA has authorized the first COVID-19 diagnostic test, which identifies whether a person has the specific antibodies known to hinder the coronavirus from entering and infecting human cells.
These neutralizing antibodies are perceived as a strong biomarker of potential immunity against the disease as compared to other antibodies created by the body that has only been used as a sign of prior exposure to the virus.
The commercial diagnostic kit developed by GenScript is designed to give a test result within one hour. However, it is still not known how lon...